Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MBX Biosciences, Inc. (MBX)
:MBX
| Dec 23 | Dec 22 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | ||
| Gross Profit | - | - |
| Operating Income | $ -35.31M | $ -26.06M |
| EBITDA | $ -32.41M | $ -25.70M |
| Net Income | $ -32.56M | $ -26.14M |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ ― | $ ― |
| Total Assets | $ 84.18M | $ 45.09M |
| Total Debt | $ 324.00K | $ 461.00K |
| Net Debt | $ -80.35M | $ -42.00M |
| Total Liabilities | $ 4.29M | $ 3.82M |
| Stockholders' Equity | $ ― | $ ― |
| Cash Flow | ||
| Free Cash Flow | $ -32.11M | $ -23.56M |
| Operating Cash Flow | $ -31.98M | $ -23.12M |
| Investing Cash Flow | ||
| Financing Cash Flow |